Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
PURPOSE: In this work, we aimed to comprehensively document the expression of Strawberry Notch homolog (SBNO) 1 and 2 in glioblastoma (GBM) tissue and patient-derived GBM stem-like cell (GSC) cultures.
METHODS: We investigated SBNO1 and SBNO2 expression at the RNA and protein levels in glioma patient tissue and GSCs, respectively by performing immunostainings and qPCR analyses. We also used publicly-available datasets for assessing SBNO1 and SBNO2 gene expression and related copy number alterations. We used lentiviral transduction of SBNO2 to analyze the effect of its expression in patient-derived GSCs.
RESULTS: We observed that SBNO2 expression is increased in GBM tissue samples compared to non tumoral brain, or lower-grade gliomas, whereas SBNO1 expression remains unchanged. We hypothesized that such SBNO2 high expression might be linked to copy-number alterations at the level of the 19p13 chromosome section. We located SBNO1 and SBNO2 in different subcellular compartments. Finally, we observed that SBNO2 overexpression induces different phenotypes in different patient-derived GSCs.
CONCLUSION: These results provide the first characterization of SBNO1 and SBNO2 expression in glioma tissue, and indicate SBNO2 as highly expressed in GBM.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:161 |
---|---|
Enthalten in: |
Journal of neuro-oncology - 161(2023), 3 vom: 28. Feb., Seite 515-523 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Coppieters, Natacha [VerfasserIn] |
---|
Links: |
---|
Themen: |
63231-63-0 |
---|
Anmerkungen: |
Date Completed 23.01.2024 Date Revised 23.01.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s11060-023-04240-7 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM352065249 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM352065249 | ||
003 | DE-627 | ||
005 | 20240124231853.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11060-023-04240-7 |2 doi | |
028 | 5 | 2 | |a pubmed24n1269.xml |
035 | |a (DE-627)NLM352065249 | ||
035 | |a (NLM)36695974 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Coppieters, Natacha |e verfasserin |4 aut | |
245 | 1 | 0 | |a Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.01.2024 | ||
500 | |a Date Revised 23.01.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
520 | |a PURPOSE: In this work, we aimed to comprehensively document the expression of Strawberry Notch homolog (SBNO) 1 and 2 in glioblastoma (GBM) tissue and patient-derived GBM stem-like cell (GSC) cultures | ||
520 | |a METHODS: We investigated SBNO1 and SBNO2 expression at the RNA and protein levels in glioma patient tissue and GSCs, respectively by performing immunostainings and qPCR analyses. We also used publicly-available datasets for assessing SBNO1 and SBNO2 gene expression and related copy number alterations. We used lentiviral transduction of SBNO2 to analyze the effect of its expression in patient-derived GSCs | ||
520 | |a RESULTS: We observed that SBNO2 expression is increased in GBM tissue samples compared to non tumoral brain, or lower-grade gliomas, whereas SBNO1 expression remains unchanged. We hypothesized that such SBNO2 high expression might be linked to copy-number alterations at the level of the 19p13 chromosome section. We located SBNO1 and SBNO2 in different subcellular compartments. Finally, we observed that SBNO2 overexpression induces different phenotypes in different patient-derived GSCs | ||
520 | |a CONCLUSION: These results provide the first characterization of SBNO1 and SBNO2 expression in glioma tissue, and indicate SBNO2 as highly expressed in GBM | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Glioblastoma | |
650 | 4 | |a Patient-derived cells | |
650 | 4 | |a Strawberry-Notch homologs 1 and 2 | |
650 | 7 | |a RNA |2 NLM | |
650 | 7 | |a 63231-63-0 |2 NLM | |
650 | 7 | |a SBNO2 protein, human |2 NLM | |
650 | 7 | |a SBNO1 protein, human |2 NLM | |
700 | 1 | |a Scalisi, Joshua |e verfasserin |4 aut | |
700 | 1 | |a Digregorio, Marina |e verfasserin |4 aut | |
700 | 1 | |a Leparc, Louise |e verfasserin |4 aut | |
700 | 1 | |a Velazquez Saez, Laetitia |e verfasserin |4 aut | |
700 | 1 | |a Lombard, Arnaud |e verfasserin |4 aut | |
700 | 1 | |a Rogister, Bernard |e verfasserin |4 aut | |
700 | 1 | |a Neirinckx, Virginie |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of neuro-oncology |d 1993 |g 161(2023), 3 vom: 28. Feb., Seite 515-523 |w (DE-627)NLM012591793 |x 1573-7373 |7 nnns |
773 | 1 | 8 | |g volume:161 |g year:2023 |g number:3 |g day:28 |g month:02 |g pages:515-523 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11060-023-04240-7 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 161 |j 2023 |e 3 |b 28 |c 02 |h 515-523 |